BPC-157
- ≥99% purity by HPLC
- Janoshik COA with every lot
- Lot-traceable from synthesis
- EU-synthesised
Specifications
Third Party Lab Tested
Every lot is independently HPLC-tested by Janoshik Analytical, Europe's reference laboratory for peptide purity assessment. The COA shipped with your order is theirs, not ours.
Storage & Handling
Lyophilized peptides should be stored below 16°C, protected from light and moisture, for up to 24 months. Once reconstituted, refrigerate and use within 30 days for protocol consistency.
Reconstitution
Reconstitute with bacteriostatic water using the volumes below. Add solvent slowly along the inside wall of the vial. Swirl gently, never shake, until fully dissolved.
Lab-handling protocol BAC Water · 0.9% benzyl alcohol The reconstitution solvent referenced above. Add to order →The body-protection
reference.
BPC-157 is a stable pentadecapeptide originally derived from a protein found in human gastric juice. Its defining property in research is structural stability - it survives the GI tract intact, which makes both oral and injectable research-protocol designs viable.
Its citation profile in tendon, ligament, and gut-tissue repair models is the deepest in its class, and it remains the single most-referenced compound in recovery-protocol research literature.
| Compound | BPC-157 |
|---|---|
| Molecular mass | 1419.5 Da |
| Mechanism / research class | Pentadecapeptide. Sequence: GEPPPGKPADDAGLV. Stable in gastric juice. |
| Lab handling solvent | 2mL bacteriostatic water for injection (BWI) |
| Resulting concentration | Yields 0.5mg per 0.1mL |
| Supply format | 10MG · Body Protection Compound lyophilized research vial |
| Storage, lyophilized | store below 16°C for up to 24 months |
| Storage, reconstituted | refrigerate and use within 30 days |
Synthesised.
Verified.
Documented.
Backed by research.
Measured in results.
Each tag opens the cited literature behind that effect. References are linked to PubMed.
BPC-157 has the deepest single-compound citation profile in tissue-repair literature, with documented effects across tendon, ligament, gut, and vascular research models.
- Chang CH et al. J Appl Physiol. 2011;110(3):774-780. PubMed ↗
BPC-157's defining structural property is stability across the GI tract. The peptide survives gastric pH intact, making both injectable and oral research-protocol designs viable.
- Sikiric P et al. The pharmacological properties of BPC-157. J Physiol Pharmacol. 1999;50(4):1-8. PubMed ↗
Documented effects on the NO pathway and angiogenic signaling underpin BPC-157's vascular-research profile, with applications in injury-recovery and ischemia-reperfusion models.
- Seiwerth S et al. BPC-157 and blood vessels. Curr Pharm Des. 2014;20(7):1121-1125. PubMed ↗
Questions?
We got answers.
Show references
Used in published research.
4.8 / 5
Solid product, fast EU shipping
Ordered BPC-157 for a research-protocol pilot. Arrived in 4 days temperature-controlled, vials sealed and properly lyophilized. Reconstituted cleanly in BWI with no haze. Will reorder.
